Abstract
Previous studies relating increased serum levels of folate and fat-soluble vitamins to prostate cancer risk have variously shown null associations or to either decrease or increase the risk of developing prostate cancer. Prospective studies of serum folate levels have been reported to show a null association and increased serum levels to either decrease or increase the risk of subsequently developing prostate cancer. Similarly, serum β-carotene and lycopene levels have either been reported to be inversely correlated or not associated with prostate cancer risk. Using a prospective nested case-control study design, which minimized the possibility of disease effects on serum-vitamin concentrations, we report null associations for serum concentrations of folate, lycopene, β-carotene, vitamin A and vitamin E, and subsequent development of prostate cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Berry G, de Klerk NH, Reid A, Ambrosini GL, Fritschi L, Olsen NJ et al. (2004). Malignant pleural and peritoneal mesotheliomas in former miners and millers of crocidolite at Wittenoom, Western Australia. Occup and Environ Med 61, e14.
Chang S, Erdman Jr JW, Clinton SK, Vadiveloo M, Strom SS, Yamamura Y et al. (2005). Relationship between plasma carotenoids and prostate cancer. Nutr Cancer 53, 127–134.
Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, Hennekens CH et al. (1999). Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res 59, 1225–1230.
Hansen J, de Klerk NH, Eccles JL, Musk AW, Hobbs MS (1993). Malignant mesothelioma after environmental exposure to blue asbestos. Int J Cancer 54, 578–581.
Hultdin J, Van Guelpen B, Bergh A, Hallmans G, Stattin P (2005). Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: a prospective study. Int J Cancer 113, 819–824.
Musk AW, de Klerk NH, Ambrosini GL, Eccles JL, Hansen J, Olsen NJ et al. (1998). Vitamin A and cancer prevention I: observations in workers previously exposed to asbestos at Wittenoom, Western Australia. Int J Cancer 75, 355–361.
Rossi E, Hung J, Beilby JP, Knuiman MW, Divitini ML, Bartholomew H (2006). Folate levels and cancer morbidity and mortality: prospective cohort study from Busselton, Western Australia. Ann Epidemiol 16, 206–212.
Thurnham DI, Smith E, Flora PS (1988). Concurrent liquid-chromatographic assay of retinol, alpha-tocopherol, beta-carotene, alpha-carotene, lycopene, and beta-cryptoxanthin in plasma, with tocopherol acetate as internal standard. Clin Chem 34, 377–381.
Weinstein SJ, Hartman TJ, Stolzenberg-Solomon R, Pietinen P, Barrett MJ, Taylor PR et al. (2003). Null association between prostate cancer and serum folate, vitamin B(6), vitamin B(12), and homocysteine. Cancer Epidemiol Biomarkers Prev 12 (11 Pt. 1), 1271–1272.
Wu K, Erdman Jr JW, Schwartz SJ, Platz EA, Leitzmann M, Clinton SK et al. (2004). Plasma and dietary carotenoids, and the risk of prostate cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev 13, 260–269.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Beilby, J., Ambrosini, G., Rossi, E. et al. Serum levels of folate, lycopene, β-carotene, retinol and vitamin E and prostate cancer risk. Eur J Clin Nutr 64, 1235–1238 (2010). https://doi.org/10.1038/ejcn.2010.124
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2010.124
Keywords
This article is cited by
-
Nutraceuticals in prostate cancer therapeutic strategies and their neo-adjuvant use in diverse populations
npj Precision Oncology (2018)
-
Increased dietary and circulating lycopene are associated with reduced prostate cancer risk: a systematic review and meta-analysis
Prostate Cancer and Prostatic Diseases (2017)
-
An Improved Method of UPLC-PDA-MS/MS Analysis of Lycopene Isomers
Food Analytical Methods (2015)
-
Folate intake, serum folate levels, and prostate cancer risk: a meta-analysis of prospective studies
BMC Public Health (2014)
-
Folate intake and the risk of prostate cancer: a systematic review and meta-analysis
Prostate Cancer and Prostatic Diseases (2014)